Johnson Winter Slattery (JWS) has advised EBR Systems, Inc. on its capital raising comprising a ~A$56 million placement and security purchase plan to raise an additional ~A$6 million.
Silicon Valley-based EBR Systems, Inc. (ASX:EBR) is dedicated to the superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless cardiac pacing. Proceeds from the capital raise will be used to advance the commercialisation strategy for EBR’s novel WiSE® CRT system following FDA approval in April 2025.
JWS advised on all legal aspects of the transaction, led by Partner Clare Brown, with Special Counsel Kate Gardner, Associate Ynan Zhou and Graduate Ada Wu.
Commenting on the deal, Clare Brown said, “I am delighted that JWS has been able to continue to support EBR Systems, Inc on its journey. Congratulations to the EBR team on a successful transaction.”
The placement was fully underwritten by J.P.Morgan and Morgans.
J.P.Morgan, Morgans, E&P Capital and Wilsons Corporate Finance acted as joint lead managers and bookrunners.
About Johnson Winter Slattery
JWS is a leading independent Australian law firm of more than 450 people, including 80+ partners. The firm is engaged by major corporates and investment funds on their most challenging transactions and disputes.
Media contacts
Angela Welsh, Marketing & Communications Manager
T: +61 2 9392 7454 | M: +61 414 281 902
E: angela.welsh@jws.com.au
Maureen Grose, Marketing & Business Development Director
T: +61 2 8247 9697 | M: +61 447 004 445
E: maureen.grose@jws.com.au
